|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
01177 SINO BIOPHARM
Nominal 
2.830 +0.020 (+0.712%) | 2023/06 - Interim RMB(K¥) | %Chg (Interim to Interim) | 2022/12 RMB(K¥) | 2021/12 RMB(K¥) | 2020/12 RMB(K¥) | 2019/12 RMB(K¥) | ||
| Turnover | 15,277,037 | 0.548% | 28,780,412 | 26,861,356 | 23,647,224 | 24,234,030 | |
| Cost of Sales | (3,256,505) | 10.032% | (5,795,510) | (5,332,095) | (5,182,320) | (4,926,268) | |
| Gross Profit | 12,020,532 | -1.746% | 22,984,902 | 21,529,261 | 18,464,904 | 19,307,762 | |
| Change in FV & Impairment on Inv. Prop. | -- | -- | -- | -- | -- | -- | |
| Change in FV & Impairment on Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) on Disposal | -- | -- | -- | -- | -- | -- | |
| Other Non-operating Items | -- | -- | -- | -- | -- | -- | |
| Share of Results of Asso. & JCEs | (219,438) | -- | (152,976) | 13,630,790 | (3,233) | 111,385 | |
| Profit / (Loss) before Taxation | 3,224,167 | -14.128% | 5,778,604 | 18,572,673 | 5,013,044 | 5,690,592 | |
| Taxation | (524,743) | -8.164% | (775,986) | (1,957,880) | (672,377) | (902,747) | |
| Profit / (Loss) from Discontinued Operations | -- | -- | -- | -- | -- | -- | |
| Non-controlling Interests | (1,440,640) | 14.139% | (2,459,048) | (2,006,381) | (1,569,581) | (2,026,303) | |
| Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) Attributable to Shareholders | 1,258,784 | -34.474% | 2,543,570 | 14,608,412 | 2,771,086 | 2,761,542 | |
| Net Finance Costs / (Income) | 115,037 | 147.802% | 237,617 | 146,560 | 129,365 | (27,759) | |
| Depreciation & Amortisation | 653,208 | 59.837% | 1,046,984 | 992,556 | 1,654,836 | 1,445,611 | |
| Directors' Emoluments | -- | -- | -- | 176,656 | 170,783 | 116,967 | |
| Auditor's Opinion Status | N/A | -- | Unqualified | Unqualified | Unqualified | Unqualified | |
Market Valuation Indicators
| EPS (cts) | 6.780 | -- | 13.660 | 77.830 | 14.740 | 14.680 |
| DPS (cts) | 1.833 | -- | 10.505 | 6.488 | 6.141 | 4.846 |
| Dividend Payout Ratio (%) | 27.036% | -- | 76.904% | 8.336% | 41.664% | 33.009% |
| Cash flow per share ($) | -- | -- | -- | 0.286 | 0.283 | 0.283 |
| NBV per share ($) | 1.594 | -- | 1.581 | 1.608 | 0.888 | 0.792 |
| Remarks: | Real time quote last updated: 29/09/2023 18:00 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders (K¥) | RMB 1,258,784 |
| %Change | -34.474% |
| EPS / (LPS) | RMB 0.068 |
| NBV Per Share (¥) | RMB 1.594 |